Shanghai Pharmaceuticals Holding Co Ltd (601607)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 16.17 |
|---|---|
| 52-week range | 15.01 – 18.56 |
| Return, 1 month / 3 months | +0.7% / −2.5% |
| Return, 1 year / 3 years | −12.0% / −4.3% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 14.8% |
| Worst drawdown (1 year) | -16.9% |
| Average daily value traded | 183.18M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shanghai Pharmaceuticals Holding is a Chinese pharmaceutical company based in Shanghai. It develops, manufactures and distributes medicines, covering chemical drugs, traditional Chinese medicines and other pharmaceutical products. The company also runs a distribution business that supplies hospitals and pharmacies across China, and it operates retail pharmacy outlets. Its customers include healthcare providers, medical institutions and consumers, and it serves both the domestic Chinese market and overseas buyers of its products.
Shanghai Pharmaceuticals Holding Co Ltd trades under the code 601607 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shanghai Pharmaceuticals Holding Co Ltd (601607) trades on the Shanghai Stock Exchange in China. It last closed at CNY 16.17 on 23 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 136 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.0% and over the last three months it fell 2.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -3.5% | ||
| From 52-week high | -12.2% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.5% | ||
| 6-month return | -4.7% | ||
| 12-month return, skipping the last month | -12.6% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 14.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.9% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 183.18M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | +0.7% |
| 3 months | −2.5% |
| 6 months | −4.7% |
| 1 year | −12.0% |
| 3 years | −4.3% |
| 5 years | −8.8% |
Signals
| 50-day / 200-day average | 16.39 / 16.76 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jul 2023 | CNY 0.6100 |
| 22 Jul 2022 | CNY 0.4200 |
| 19 Jul 2021 | CNY 0.4800 |
| 20 Jul 2020 | CNY 0.4400 |
| 16 Jul 2019 | CNY 0.4100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.